Fibulin-3, -4, and -5 Are Highly Susceptible to Proteolysis, Interact with Cells and Heparin, and Form Multimers
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Extracellular short fibulins, fibulin-3, -4, and -5, are components of the elastic fiber/microfibril system and are implicated in the formation and homeostasis of elastic tissues. In this study, we report new structural and functional properties of the short fibulins. Full-length human short fibulins were recombinantly expressed in human embryonic kidney cells and purified by immobilized metal ion affinity chromatography. All three fibulins showed various levels of degradation after the purification procedure. N-terminal sequencing revealed that all three fibulins are highly susceptible to proteolysis within the N-terminal linker region of the first calcium-binding epidermal growth factor domain. Proteolytic susceptibility of the linker correlated with its length. Exposure of these fibulins to matrix metalloproteinase (MMP)-1, -2, -3, -7, -9, and -12 resulted in similar proteolytic fragments with MMP-7 and -12 being the most potent proteases. Fibulin-3 proteolysis was almost completely inhibited in cell culture by the addition of 25 μm doxycycline (a broad spectrum MMP inhibitor). Reducible fibulin-4 dimerization and multimerization were consistently observed by SDS-PAGE, Western blotting, and mass spectrometry. Atomic force microscopy identified monomers, dimers, and multimers in purified fibulin-4 preparations with sizes of ∼10–15, ∼20–25, and ∼30–50 nm, respectively. All short fibulins strongly adhered to human fibroblasts and smooth muscle cells. Although only fibulin-5 has an RGD integrin binding site, all short fibulins adhere at a similar level to the respective cells. Solid phase binding assays detected strong calcium-dependent binding of the short fibulins to immobilized heparin, suggesting that these fibulins may bind cell surface-located heparan sulfate. Background: Fibulin-3, -4, and -5 (short fibulins) participate in elastogenesis, although the molecular mechanism remains unknown. Results: Short fibulins are cleaved by MMPs and bind cells and heparin, and fibulin-4 dimerizes and multimerizes. Conclusion: Short fibulins have a proteolytically susceptible linker and can bind cells independently of the RGD motif, and fibulin-4 multimerization is crucial for heparin binding. Significance: The uncovered properties will advance understanding of elastogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirai, M., Ohbayashi, T., Horiguchi, M., Okawa, K., Hagiwara, A., Chien, K. R., Kita, T., & Nakamura, T. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611026 · Cited by 165 · cited 4×
“(19) is no longer able to participate in elastogenesis.”
BackgroundInfluential
Cited by
A local complement response by RPE causes early-stage macular degeneration
Fernandez-Godino, R., Garland, D. L., & Pierce, E. A. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv287 · Cited by 73
“EFEMP1 belongs to the fibulin family of ECM proteins and is thought to be involved in elastogenesis (37).”
BackgroundMackay, D. S., Bennett, T. M., & Shiels, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132529 · Cited by 71
“Arg140Trp mutation identified here is located in the first cbEGF-like domain within a protease-sensitive linker region of 88 amino acids (Fig 3) separating the fourth and fifth conserved cysteine residues [31].”
BackgroundWozny, M. R., Nelea, V., Siddiqui, I. F. S., Wanga, S., de Waard, V., Strauss, M., & Reinhardt, D. P. (2024) · Nature Communications · doi:10.1038/s41467-024-48377-z · Cited by 9
Self-citation
Metadata
- Authors
- Djokic, J., Fagotto-Kaufmann, C., Bartels, R., Nelea, V., & Reinhardt, D. P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 288
- Issue
- 31
- Pages
- 22821-22835
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1999472620
- Cited by
- 51
- References
- 1
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.